Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Fate Therapeutics Announces September Investor Events
-
Pliant Therapeutics To Participate In Upcoming Virtual Investor Conferences
-
UNITY Biotechnology to Participate in Upcoming September Investor Conferences
-
Fate Therapeutics Announces September Investor Events
-
Caledonia Mining Corporation Plc: Completion of ATM Fund-Raising for Solar Project, Block Admission Cancellation and Block Admission Return
-
Caledonia Mining Corporation Plc: Completion of ATM Fund-Raising for Solar Project, Block Admission Cancellation and Block Admission Return
-
Satsuma Pharmaceuticals to Participate in September Virtual Investor Conferences
-
Crinetics Pharmaceuticals to Participate in September Investor Conferences
-
Crinetics Pharmaceuticals to Participate in September Investor Conferences
-
HighCape Capital Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
-
AGTC to Participate at Upcoming Virtual Investor Conferences
-
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
-
Cohen & Company Announces Pricing of INSU Acquisition Corp. II Upsized $200,000,000 Initial Public Offering
-
Cohen & Company Announces Pricing of INSU Acquisition Corp. II Upsized $200,000,000 Initial Public Offering
-
Kriya Therapeutics To Present At Upcoming Healthcare Conferences
-
BioDelivery Sciences to Present at Two Upcoming Investor Conferences
-
X4 Pharmaceuticals to Participate in Three September Virtual Investor Conferences
-
Molecular Templates to Participate in September Virtual Investor Conferences
-
GBT Announces Participation in Upcoming Investor Conferences
-
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
-
uniQure to Participate in Multiple Upcoming Industry Conferences in September
-
Sutro Biopharma to Present at Two Upcoming Investor Conferences
-
UPDATE: INSU Acquisition Corp. II (INAQ) Prices Upsized 20M Unit IPO at $10/Unit
-
INSU Acquisition Corp. II Announces Pricing of Upsized $200,000,000 Initial Public Offering
-
INSU Acquisition Corp. II Announces Pricing of Upsized $200,000,000 Initial Public Offering
-
Prevail Therapeutics to Present at Upcoming Investor Conferences
-
Prevail Therapeutics to Present at Upcoming Investor Conferences
-
Viking Therapeutics to Participate in Upcoming Investor Conferences
-
Cidara Therapeutics to Participate in Upcoming Investor Conferences
-
Cidara Therapeutics to Participate in Upcoming Investor Conferences
-
MyoKardia to Participate in September Investor Conferences
-
XOMA to Present at Upcoming Investor Conferences
-
BrainsWay Announces Presentations at Upcoming Investor Conferences
-
Trevena, Inc. to Present at September Virtual Investor Conferences
-
Affimed to Present at Upcoming Investor Conferences
-
Affimed to Present at Upcoming Investor Conferences
-
ACG Analytics and Makor Oscar Gruss to Form Partnership
-
CF Finance Acquisition Corp. II Announces Closing of $500 Million Initial Public Offering
-
Form 8-K Cantor Fitzgerald Income For: Aug 31
-
Opiant Pharmaceuticals to Participate at the 2020 Cantor Global Virtual Healthcare Conference
-
Opiant Pharmaceuticals to Participate at the 2020 Cantor Global Virtual Healthcare Conference
-
IDEAYA to Participate in Upcoming September 2020 Investor Relations Events
-
FTAC Olympus Acquisition Corp. Announces Completion of $750,000,000 Initial Public Offering
-
FTAC Olympus Acquisition Corp. Announces Completion of $750,000,000 Initial Public Offering
-
Pre-Open Stock Movers 8/28: (IBIO) (NTNX) (TRVN) Higher; (PLT) (BILL) (OKTA) Lower (more...)
-
Stereotaxis to Present at Three Investor Conferences in September
-
Fortress Biotech (FBIO) Announces $60 Million Loan Agreement with Oaktree Capital Management
-
Entasis Therapeutics Holdings Inc. (ETTX) Announces $25 Million Private Placement of Common Stock, Warrants
-
Entasis Therapeutics Announces $25 Million Private Placement

